Want to see OLMA full AI Analyst Report?
Olema Pharmaceuticals (OLMA) Income Statement
Olema Pharmaceuticals Income Statement
Last quarter (Q2 2026), Olema Pharmaceuticals's total revenue was $0.00. In Q2, Olema Pharmaceuticals's net income was $-63.20M. See Olema Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 178.70M | $ 142.26M | $ 104.96M | $ 106.99M | $ 71.49M | |
| Depreciation and Amortization | $ 490.00K | $ 393.00K | $ 377.00K | $ 357.00K | $ 163.00K |
| $ -161.96M | $ -129.08M | $ -96.28M | $ -104.43M | $ -70.93M | |
| $ -178.70M | $ -142.26M | $ -104.96M | $ -106.99M | $ -71.49M | |
| $ 16.25M | $ 12.78M | $ 8.31M | $ 2.20M | $ 395.00K | |
| $ -162.45M | $ -129.47M | $ -96.66M | $ -104.79M | $ -71.10M | |
| $ -162.45M | $ -129.47M | $ -96.66M | $ -104.79M | $ -71.10M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.87 | $ -2.20 | $ -2.14 | $ -2.62 | $ -1.79 |
| Diluted EPS | $ -1.87 | $ -2.20 | $ -2.14 | $ -2.62 | $ -1.79 |
| Weighted Average Shares Outstanding | 87.01M | 58.74M | 45.25M | 40.00M | 39.52M |
| Weighted Average Shares Outstanding (Diluted) | 87.01M | 58.74M | 45.25M | 40.00M | 39.52M |
Currency in USD
